Graft Versus Host Disease (GvHD) Treatment Market Outlook, 2024-2028 & 2033 - Revenue Shares for Corticosteroids, Monoclonal Antibodies, Immunosuppressants and Other Products
10. Dezember 2024 09:45 ET
|
Research and Markets
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) Treatment Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This GvHD treatment...
Graft Versus Host Disease (GvHD) Treatment Industry Forecast Report, 2024-2032 - Global Market Size Forecast to Double, with Emerging Markets Offering Substantial Growth Potential
07. November 2024 09:47 ET
|
Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) Treatment Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The graft...
Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight
22. September 2024 00:30 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight The graft versus host disease...
Graft Versus Host Disease (GvHD) Treatment Market Analysis, 2018-2023 and 2024-2030: Corticosteroids, Hospitals, and North America Will Dominate During the Forecast Period
12. April 2024 10:03 ET
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ...
Global Graft Versus Host Disease Treatment Market 2023-2030: Monoclonal Antibodies Lead Surge in Graft Versus Host Disease Treatment Market, Monitored by Comprehensive Vendor Analysis
13. September 2023 06:54 ET
|
Research and Markets
Dublin, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Graft Versus Host Disease Treatment Market by Disease Type, Product, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...
Photopheresis Products Market to exceed USD 488 billion by 2032, says Global Market Insights Inc.
27. Juni 2023 07:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, June 27, 2023 (GLOBE NEWSWIRE) -- Photopheresis Products Market size is predicted to surpass USD 488 billion by 2032. Advancements in medical technology and increasing demand...
Global Graft Versus Host Disease Treatment Market 2022-2027:Annual Growth of 9.21% Driven by Key Players GlaxoSmithKline, Pfizer, Merck
30. August 2022 05:28 ET
|
Research and Markets
Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "Global Graft Versus Host Disease Treatment Market (2022-2027) by Disease Type, Product, Geography, Competitive Analysis and the Impact of Covid-19 with...
Graft Versus Host Disease Treatment Market Report 2021-2028 | Size, Share, Growth Factors, Restraining Factors, Revenue, Competitive Landscape, Forecast Analysis
14. Oktober 2021 06:23 ET
|
Fortune Business Insights
Pune, India, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The global “graft versus host disease treatment market” size is slated to experience a rugged expansion period on account of rising number of allogenic...
Mesoblast’s Japan Licensee Receives Pricing for TEMCELL® HS Inj. for Treatment of Acute Graft Versus Host Disease
27. November 2015 06:00 ET
|
Mesoblast Limited
MELBOURNE, Australia and NEW YORK, Nov. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that its licensee in Japan, JCR Pharmaceuticals Co. Ltd., has received...
Mesoblast Chairman's Address to 2015 Annual General Meeting
22. Oktober 2015 02:00 ET
|
Mesoblast
NEW YORK, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Thank you for attending the Mesoblast 2015 Annual General Meeting.
This has been another exciting and productive year in the history of our...